|
Post by sophie on May 1, 2018 13:38:30 GMT -5
Head-scratching for sure that an endocrinologist with this much knowledge and passion for the product wouldn't be able to contribute significantly to the weekly script count. I understand insurance is a barrier, but it would seem the endo would tell the patient to switch to a plan that at least has a PA option.
|
|
|
Post by sayhey24 on May 1, 2018 19:34:59 GMT -5
brentie - You're awesome!!! She was an endo, not an OB/Gyn, but still - lots of pregnant pts. Her testimony was very convincing. The good doctor says she cares for 4000 patients per year. I wonder what trials her patients where part of and how many participated. I wonder if any follow-up has been done to see how the babies are doing. When they say it was never tested in pregnant women maybe thats not really the case. This one doctor has enough patients to do a single site trial. I sure hope Dr. Kendell has been following up with doctors like this. 80 scripts per week is a big number given total scripts are in the 400's.
|
|
|
Post by mytakeonit on May 1, 2018 21:51:21 GMT -5
Kinda makes you feel that all scripts aren't reported ... SO ... need more shares!!!
|
|
|
Post by nylefty on May 1, 2018 23:00:42 GMT -5
Kinda makes you feel that all scripts aren't reported ... SO ... need more shares!!! All scripts are NOT reported. The numbers we see are estimates, not hard numbers.
|
|
|
Post by dreamboatcruise on May 2, 2018 1:40:17 GMT -5
Kinda makes you feel that all scripts aren't reported ... SO ... need more shares!!! Well... all revenue received is reported by MNKD, and the amount reported by MNKD is, as would be expected, lower than the reported retail revenue from Symphony. So regardless as to whether Symphony's estimate is above or below the actually number of scripts... we know the revenue to MNKD is and will be significantly below the retail revenue reported by Symphony. Symphony is mostly useful for monitoring the trend... which is still growing way to slow.
|
|